查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1632061

恆电位仪：全球市场占有率分析、产业趋势/统计、成长预测（2025-2030）

Global Potentiostat - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计全球恆电位仪市场在预测期内的复合年增长率为 2.7%。

全球恆电位仪-市场-IMG1

主要亮点

  • 减少前置作业时间、样品使用量、测试成本以及与各种技术相关的限制的愿望导致了技术创新和恆电位仪技术的创建。这些筛检的筛检采用预计将在媒介中增加，并且它为小型实验室提供了扩大其服务范围并与行业中较大的市场参与者竞争的机会。
  • 2021 年 2 月，生物技术巨头 Biocon 旗下子公司 Biocon Biologics 宣布，作为癌症获取合作伙伴关係的一部分，计划在非洲和亚洲 30 多个国家扩大救生癌症生物仿製药的使用范围。 CHAI) 达成协议。这种合作可能会创造市场成长的机会。
  • 随着恆电位仪产品的使用量不断增加，许多研究人员正在其製造过程中进行研究，许多研究人员正在使产品对客户更有用。例如，2022 年6 月，一项题为「基于ESP32 微控制器的用于循环伏安分析的智慧型手机控制的低成本恆电位仪设计」的研究发现，基于电化学的分析具有我认为的简单、弹性和低维护的优点。恆电位仪是进行电化学实验和分析的基本仪器，特别是出于教育目的，开发低成本恆电位仪以允许中小型教育单位建立多功能迷你实验室是必要的。此外，为了吸引大量技术采用者，必须开发小型便携式设备。我们创建了 eSTAT，这是一种使用 ESP32 微控制器的低成本、智慧型手机控制的恆电位仪系统。为了评估 eSTAT 的性能，使用循环伏安法 (CV) 测量来评估系统的准确性和容错接受度。基于 ESP32 微控制器的智慧型手机控制低成本恆电位仪设计，用于循环伏安分析。
  • COVID-19 大流行对全球各行业的供应链造成了严重破坏，导致世界各地许多公司暂停或减少业务以对抗病毒的传播。疫情影响了无源电子元件业务，导致整个供应链的营运水准下降，特别是在元件和原料层面。这表示某些地区和国家的销售额出现下降。
  • 近期镍、铁、钼等原物料价格大幅波动。受疫情影响，全球贵金属市场供应链问题进一步负面影响，进一步影响市场价格。根据世界银行的数据，2021年2月镍价为每吨18,584.38美元，2020年12月镍价为每吨16,823.04美元。原材料成本上涨阻碍了生产并增加了营运成本。

恆电位仪市场趋势

製药业的应用是推动市场的因素之一

  • 鑑于药品使用和误用的增加，药品分析是一个重要的主题，涉及原料、配方和生物样本中活性成分的鑑定和评估。进行杂质、降解产物、辅料、含量均匀度、溶离度、稳定性测试等测定。引用了许多应用，包括药物品管、治疗药物监测、药物动力学和临床研究。
  • 2022年3月，发表了题为「A Wireless Implantable Potentiostat for 可程式设计 Electrochemical Drug Delivery」的研究论文。研究人员提出了超音波驱动的植入式恆电位仪，具有双向通讯，用于可程式设计电化学控制药物传输。该系统由独特的药物传输模组、载药电响应奈米颗粒和用于无线电源和资料的压电换能器、180nm CMOS 积体电路和180nm CMOS 积体电路组成。该晶片包括一个可编程宽范围恆电位仪，可产生高达 1.5V 的电位并测量高达 100A 的电流，以及一个 125kbps资料发送器。该药物输送系统已被证明可以无线供电并控制萤光素的释放。
  • FDA 药物评估与研究中心 (CDER) 2021 年核准了50 种新药和生物製药。在核准的50个新药和生物製药中，有33个是小分子药物，17个是单株抗体或其他大分子药物。然而，近年来生物製药的核准稳步增加。这些新兴国家的发展预计将对市场产生正面影响。
  • 多家公司正在合作开发新药和治疗方法，我们相信这将是开发市场的绝佳机会。例如，2022年4月，Astellas来製药和东京大学开始了第二阶段的合作研究，共同发现新的疗法和医疗解决方案。Astellas来联盟加速计画是此次合作的名称 (AAAP)。第一阶段从2020年9月至2022年3月，AAAP为大学生命科学研究与教育研究所与东京大学创新中心的合作奠定了基础。
  • 此外，2021 年 11 月，牛津大学和巴西卫生署宣布了一项联合倡议，将在巴西建立全球健康、合约和临床研究单位。该部门开发新药和疫苗，以推进正在进行的人类健康研究。我们还将提供感染疾病、临床开发和疫苗学方面的硕士和博士生以及课程，并将重点培养新一代合约研究人员和临床研究人员。

美洲占主要市场占有率

  • 美国食品药物管理局(FDA) 监管美国的药品生产。 FDA 透过密切监控药品製造商遵守现行良好生产规范 (CGMP) 法规的情况来确保药品品质。药品 CGMP 法规对用于製造、加工和包装药品的方法、设备和控制设定了最低要求。这些法规确保产品使用安全，并含有适合其功效和功效的成分。这些法规为应用程式的处理、内容和评估制定了指导方针，并规范了产品的设计、製造、製造和测试。这推动了市场。
  • 可携式恆电位仪是一种紧凑的便携式电池供电设备。它们的性能通常不如桌上型电脑型号，而且它们的用途往往受到限制。手持式恆电位仪特别适合现场测试，其中快速定量结果比完整的电化学研究更重要。
  • 当地公司开发新产品或将新技术融入现有产品以满足客户需求。例如，总部位于美国的 Pine Research Instrumentation 提供 WaveNow 无线恆电位仪/恆定电流仪，这是一种可用于多种应用的多功能係统。它只比智慧型手机大一点，但坚固耐用，并且能够执行所有传统的电化学过程。 WaveNow 的电流解析度为 100 nA 至 100 mA，电压范围为 +/-4 V。 WaveNow 供教育环境、研究和工业实验室的客户使用。
  • 2021 年 2 月，科学家开发了一种邮票大小的晶片，使 COVID-19 测试变得更加容易，并在智慧型手机上在 55 分钟内提供观察。美国莱斯大学的研究人员开发了一种微流体晶片，可以分析透过常规手指刺破收集的血清中SARS-CoV-2 核衣壳(N) 蛋白的浓度，该蛋白是COVID-19 的生物标誌物。透过将血清稀释五倍，微晶片能够在 25 分钟内辨识出浓度较低的 N 蛋白（每毫升 10 皮克）。当Google Pixel 2行动电话与插入式恆电位仪结合使用时，血清浓度低至 230 皮克即可获得阳性诊断。本设备可调节电压并检测产生的电流。
  • 由于工作电极接地，因此对杂讯不敏感，电位和电流记录器输出均指向地，从而可以测量极小的电流，并且可以采用不同的基本恆电位仪设计。诸如此类的优势为本地参与者创造了透过各种测试应用程式扩展业务的机会。

恆电位仪产业概况

全球恆电位仪市场分散。为了满足保险业不断变化的需求，参与者倾向于投资其产品的创新。此外，参与者正在采取伙伴关係、合併和收购等策略活动来扩大其影响力。近期市场发展趋势如下：

  • 2021 年 6 月 - 继 VSP-3e 和 VMP-3e 取得成功之后，SP-50e 和 SP-150e 是 BioLogic Essential 系列恆电位仪「e」（改良型）系列的最新成员。 SP-150e 是成熟的 SP-150 的升级版本。与之前的型号相比，进行了多项改进。能够为恆电位仪增加第二个通道是 SP-150e 的重要功能。此小型多通道双恆定电位器增加了第二个通道，使得此电化学工作站特别适合能源应用。添加第二个通道扩大了用户可用的应用范围，特别是在电池测试和一般电化学方面。
  • 2021 年 5 月 - Admiral Instruments 宣布与 Quantum Design 建立新的合作关係。他们的目标是让世界各地的每个人都能使用下一代电化学设备，Quantum Design 很高兴能够支持义大利的这项努力。虽然传统的恆电位仪非常昂贵且难以操作，但此次合作推出了 Squidstat 恆电位仪，它将强大的技术融入较小的占地面积中，并提供市场领先的价格。此外，这个应用程式提供了一个非常基本的使用者介面。 Admiral 实现了这一切，同时保持了此类精密设备所需的研究级品质。

其他好处：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场洞察

  • 市场概况
  • 产业吸引力－波特五力分析
    • 新进入者的威胁
    • 买方议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第五章市场动态

  • 市场驱动因素
  • 市场挑战
  • 产业价值链分析（生态系统、通路、相关人员分析）
  • COVID-19 对市场的影响
  • 技术简介

第六章 市场细分

  • 按最终用户使用情况
    • 药品
    • 环境
    • 食品检验
    • 水质测试
    • 其他的
  • 按地区
    • 北美洲（北美洲、拉丁美洲）
    • 欧洲、中东和非洲 (EMEA)
    • 亚太地区

第七章 竞争格局

  • 公司简介
    • Metrohm AG
    • AMETEK Inc.
    • BioLogic Sciences Instruments SA
    • Danaher Corp.
    • Gamry Instruments
    • Harvard Bioscience Inc.
    • Ivium Technologies BV
    • Metrohm AG

第8章小型恆电位仪应用的研究论文引用

第九章 市场未来展望

简介目录
Product Code: 90983

The Global Potentiostat Market is expected to register a CAGR of 2.7% during the forecast period.

Global Potentiostat - Market - IMG1

Key Highlights

  • The desire to reduce lead time, sample usage, testing costs, and limitations associated with various technologies has resulted in technological innovation and the creation of potentiostat technologies. Because these technologies offer higher sensitivity, accuracy in results, reliability, multi-contaminant and non-targeted screening with low turnaround time, and other benefits, wide-scale adoption of these technologies provides an opportunity for medium- and small-scale laboratories to expand their service offerings and compete with large market players in the industry.
  • In February 2021, Biocon Biologics, an arm of biotechnology major Biocon, announced that it had signed a pact with the Clinton Health Access Initiative (CHAI) to expand access to life-saving cancer biosimilars in over 30 countries in Africa & Asia as a part of the Cancer Access Partnership. Collaborations like this will create an opportunity for the market to grow.
  • With the increase in the usage of potentiostat products lot of researchers are in the process of making it, and many researchers are making the product more useful to the customer. For instance, in June 2022, the research titled" Design of smartphone-controlled low-cost potentiostat for cyclic voltammetry analysis based on ESP32 microcontroller" states that electrochemical-based analysis has the advantages of simplicity, resilience, and low maintenance. A low-cost potentiostat, a basic piece of equipment for conducting electrochemistry experiments and analysis, is required to enable small-medium educational units to construct a multipurpose mini-laboratory, especially for educational purposes. Furthermore, developing portable and small devices may be required to attract many technology adopters. The ESP32 microcontroller was used to create eSTAT, a low-cost, smartphone-controlled potentiostat system. The accuracy and error tolerance of the system was assessed using Cyclic Voltammetry (CV) measurements, which were used to evaluate eSTAT's performance. Design of smartphone-controlled low-cost potentiostat for cyclic voltammetry analysis based on ESP32 microcontroller.
  • The COVID-19 pandemic has led to enormous disruptions in supply chains across industries globally, due to which many businesses worldwide halted or reduced operations to help combat the spread of the virus. The pandemic has impacted the passive electronic components business, resulting in lower operation levels across the supply chain, particularly at the component and raw material levels. This indicates a drop in sales across several regions and countries.
  • The prices of raw materials such as nickel, iron, molybdenum, etc., have recently seen significant changes. With the influence of the pandemic, the global precious metal market is further witnessing adverse effects of supply chain issues, which are further impacting the prices in the market. According to the World Bank, the nickel price stood at USD 18,584.38 in February 2021, which was USD 16,823.04 per metric ton in December 2020. The increase in the raw material cost will hamper production and increase the operational cost.

Potentiostat Market Trends

Applications in Pharmaceutical Industry is One of the Factor Driving the Market

  • Pharmaceutical analysis is a significant subject connected to active component identification and evaluation in raw materials, pharmaceutical formulations, and biological samples in the current context of rising drug use and misuse. Impurities, degradation products, and excipients are determined, as well as content uniformity, dissolution, and stability tests. Medication quality control, therapeutic drug monitoring, pharmacokinetics, and clinical investigations are a few of the many cited uses.
  • In March 2022, the research paper titled" A Wireless Implantable Potentiostat for Programmable Electrochemical Drug Delivery" States that Targeted, tailored, and on-demand therapies with minimal side effects are possible using implantable drug delivery devices. The researchers present an ultra-sonically powered implantable potentiostat with bidirectional communication for programmable electrochemically controlled drug delivery. A unique drug delivery module incorporating drug-loaded electro-responsive nanoparticles and piezoelectric transducers for wireless power and data, a 180 nm CMOS integrated circuit, and a 180 nm CMOS integrated circuit make up the system. A programmable wide-range potentiostat capable of producing potentials up to 1.5 V and measuring currents up to 100 A and a 125 kbps data transmitter is included in the chip. The medication delivery system is demonstrated using wirelessly powered and regulated fluorescein release.
  • The FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs and biological products in 2021. Of the 50 approved new drugs and biological products, 33 were small molecule drugs, and 17 were monoclonal antibodies and other big molecule drugs. However, biologic approvals have been increasing steadily over the past few years. Such developments will positively impact the market.
  • Several firms are collaborating in developing new drugs, therapies, and many more, which will significantly create an opportunity for the market to grow. For Instance, in April 2022, Astellas Pharma and the University of Tokyo launched the second phase of their collaboration to discover novel therapeutics and medical solutions together. The Astellas Alliance Acceleration Program is the name of the collaboration (AAAP). AAAP established a foundation for the collaboration at the university's Institute for Life Science Research and Education and the University of Tokyo Center of Innovation during the initial phase, which lasted from September 2020 to March 2022.
  • Furthermore, In November 2021, The University of Oxford and the Brazilian Ministry of Health announced a joint initiative to set up global health and contract and clinical research unit in Brazil. It will develop new drugs and vaccines to drive ongoing human health research. It will also focus on training a new generation of contract and clinical researchers by offering Masters and Ph.D. studentships and courses in infectious diseases, clinical development, and vaccinology.

Americas to Hold the Major Market Share

  • The US Food and Drug Administration (FDA) regulates the manufacturing of drugs in the United States. It ensures the quality of drug products by carefully monitoring drug manufacturers' compliance with its Current Good Manufacturing Practice (CGMP) regulations. The CGMP regulations for drugs have set the minimum requirements for the methods, facilities, and controls used in drug manufacturing, processing, and packaging. These regulations ensure that a product is safe for use and includes the ingredients according to the claims. These regulations lay down guidelines for processing, content, and evaluation of applications and regulating products' design, production, manufacturing, and testing. This will drive the market.
  • Portable potentiostats are compact, battery-powered instruments that can be carried around. They are often less powerful than desktop models and are more likely to be limited to a single purpose. Handheld potentiostats are ideal for testing in the field, especially where a quick quantitative result is more critical than a complete electrochemical study.
  • The regional companies are developing new products or incorporating new techniques into existing products to meet customers' demands. For example, Pine Research Instrumentation, Inc., a United States-based company, provides a WaveNow Wireless potentiostat/galvanostat, a versatile system that can be used in various applications. Even though it is just larger than a smartphone, it is highly strong, sturdy, and capable of performing all traditional electrochemical processes. WaveNow has a current resolution of 100 nA to 100 mA and a voltage range of +/- 4 V. WaveNow is used in a teaching environment, research, and industrial laboratories by customers.
  • In February 2021, scientists developed a stamp-sized chip that makes COVID-19 testing easier and provides findings in less than 55 minutes on a smartphone. Researchers from Rice University in the United States created a microfluidic chip that analyses the concentration of SARS-CoV-2 nucleocapsid (N) protein, a biomarker for COVID-19, in blood serum from a routine finger prick. By diluting the serum fivefold, the microchip could identify N protein at even lower quantities, at ten picograms per milliliter, in 25 minutes. It produced a positive diagnosis with a concentration as low as 230 picograms for the entire serum when paired with a Google Pixel 2 phone and a plug-in potentiostat. This device adjusts voltage and detects the resulting current.
  • Due to the working electrode being grounded, it is noise-insensitive - the recorder outputs of both potential and current refer to ground, extreme small currents can be measured, and different basic potentiostat designs can be employed. Benefits like these will create an opportunity for the local players to expand their business in different testing applications.

Potentiostat Industry Overview

The Global Potentiostat Market is fragmented. Players tend to invest in innovating their product offerings to cater to the insurance industry's changing demands. Moreover, players adopt strategic activities like partnerships, mergers, and acquisitions to expand their presence. Some of the recent developments in the market are:

  • June 2021 - Following the success of the VSP-3e and VMP-3e, the SP-50e and SP-150e are the latest additions to BioLogic's Essential line's "e" (improved) series of potentiostats. The SP-150e is an upgraded, updated version of the tried-and-true SP-150. It has several improvements over its predecessor. The ability to add a second channel to the potentiostat is a crucial feature of the SP-150e. Including a second channel to this tiny, multichannel bipotentiostat makes this electrochemical workstation particularly well suited to energy applications. The addition of a second channel expands the range of applications available to users, particularly in battery testing and general electrochemistry.
  • May 2021 - Admiral Instruments has announced a new cooperation with Quantum Design. Their purpose is to make the next generation of electrochemistry equipment accessible to everyone worldwide, and quantum design is excited to assist them in this endeavor in Italy. Traditional potentiostats are notoriously expensive and difficult to operate; however, in this collaboration, the company employs Squidstat potentiostats, which pack strong technology into a small footprint at a market-leading price. The app also provides a delightfully basic user interface. Admiral accomplishes all this while maintaining the research-grade quality required of precision instruments in this class.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Threat of New Entrants
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Bargaining Power of Suppliers
    • 4.2.4 Threat of Substitutes
    • 4.2.5 Intensity of Competitive Rivalry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
  • 5.2 Market Challenges
  • 5.3 Industry Value Chain Analysis (Ecosystem, Distribution Channel, and Stakeholder Analysis)
  • 5.4 Impact of COVID-19 on the Market
  • 5.5 Technological Snapshot

6 MARKET SEGMENTATION

  • 6.1 By End-User Application
    • 6.1.1 Pharmaceutical
    • 6.1.2 Environmental
    • 6.1.3 Food testing
    • 6.1.4 Water Testing
    • 6.1.5 Others
  • 6.2 By Geography
    • 6.2.1 Americas (North America, Latin America)
    • 6.2.2 Europe, Middle East and Africa (EMEA)
    • 6.2.3 Asia Pacific

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Metrohm AG
    • 7.1.2 AMETEK Inc.
    • 7.1.3 BioLogic Sciences Instruments SA
    • 7.1.4 Danaher Corp.
    • 7.1.5 Gamry Instruments
    • 7.1.6 Harvard Bioscience Inc.
    • 7.1.7 Ivium Technologies BV
    • 7.1.8 Metrohm AG

8 RESEARCH PAPER CITATION ON THE MINIATURIZED POTENTIOSTAT APPLICATION

9 MARKET FUTURE OUTLOOK